四環醫藥(00460.HK)醋酸奧曲(月太)注射液通過內地一致性評價
四環醫藥(00460.HK)公布,集團的醋酸奧曲(月太)注射液(1ml:0.05mg及1ml:0.1mg),已獲得中國國家藥品監督管理局頒發的藥品補充申請批准通知書,批准該藥品通過質量和療效一致性評價,為該品種首家通過一致性評價。
集團指,醋酸奧曲(月太)為國家醫保乙類藥品,是人工合成的天然生長抑素的八(月太)衍生物,較天然生長抑素半衰期明顯延長且有相同的藥理作用,包括抑制生長激素功能,抑制胃酸、胰(酉每)、胰高血糖素和胰島素的分泌,減少內臟血流量,降低胃腸道運動等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.